1. Product Description
Topical acne formulations utilizing Invisicare have been designed to maximize drug efficacy as a treatment for bacteria that cause acne while maintaining the skin's own natural moisture level.
2. Patent-Pending Formulas
Skinvisible® has developed several topical acne cream formulations with Invisicare and four active ingredients: (1) retinoic (2) clindamycin. These patent-pending formulations use various surfactants to control and extend the release of the active ingredients.
3. Increased Efficacy with Controlled Release
In vitro studies have demonstrated that topical formulations with Invisicare can control the release of the active ingredient both immediately and over a two hour period.
4. Exclusive Delivery System
At the core of Skinvisible's topical formulations is the patented delivery system Invisicare. This proprietary polymer delivery system has been proven to hold active ingredients on the skin for up to four hours and longer.
In vivo studies confirm that Invisicare binds to the skin's outer layer while resisting perspiration and water wash-off.
Equally important, Invisicare forms a protective barrier that helps keep the skin moist, which is beneficial to the healing process.
5. License Available
Skinvisible is offering the right to license these patent-pending product formulations incorporating Invisicare for the OTC and prescription pharmaceutical market.